Concepedia

Rongrong Bi

RB

Statistics

Publications

5

Citations

167

H-Index

5

Active since

2017

Affiliations

Longhua Hospital Shanghai University of Traditional Chinese Medicine(Current)

Shanghai Ninth People's Hospital

Shanghai University of Traditional Chinese Medicine

Rongrong Bi is an author at Longhua Hospital Shanghai University of Traditional Chinese Medicine specializing in pancreatic cancer, medicine, and oncology.

ORCID

Publications per year

2017–2021

5

Publications

5

lncRNA ANRIL aggravates the chemoresistance of pancreatic cancer cells to gemcitabine by targeting inhibition of miR-181a and targeting HMGB1-induced autophagy

Lei Wang, Rongrong Bi, Lei Li et al. · Aging · 2021 · 47 citations · Full text

, , +17

ENO1 silencing impaires hypoxia-induced gemcitabine chemoresistance associated with redox modulation in pancreatic cancer cells.

Lei Wang, Rongrong Bi, Hang Yin et al. · PubMed · 2019 · 46 citations · Full text

, , +17

ENO1‐targeted superparamagnetic iron oxide nanoparticles for detecting pancreatic cancer by magnetic resonance imaging

Lei Wang, Hang Yin, Rongrong Bi et al. · Journal of Cellular and Molecular Medicine · 2020 · 32 citations · Full text

, , +17

Endothelial cell autophagy in chronic intermittent hypoxia is impaired by miRNA‐30a‐mediated translational control of Beclin‐1

Rongrong Bi, Yan-Cheng Dai, Zifeng Ma et al. · Journal of Cellular Biochemistry · 2018 · 26 citations

, , +17

A Privacy-Preserving and Vessel Authentication Scheme Using Automatic Identification System

Pengchuan Su, Nan Sun, Liehuang Zhu et al. · 2017 · 16 citations

, , +17

1–5 of 5